
Rigel Pharmaceuticals Inc
NASDAQ:RIGL

Intrinsic Value
The intrinsic value of one
RIGL
stock under the Base Case scenario is
35.57
USD.
Compared to the current market price of 20.17 USD,
Rigel Pharmaceuticals Inc
is
Undervalued by 43%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Rigel Pharmaceuticals Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Rigel Pharmaceuticals Inc
Balance Sheet Decomposition
Rigel Pharmaceuticals Inc
Current Assets | 146.6m |
Cash & Short-Term Investments | 77.1m |
Receivables | 41.5m |
Other Current Assets | 27.9m |
Non-Current Assets | 29.4m |
PP&E | 1.4m |
Intangibles | 26.5m |
Other Non-Current Assets | 1.5m |
Free Cash Flow Analysis
Rigel Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Rigel Pharmaceuticals Inc
Revenue
|
203.1m
USD
|
Cost of Revenue
|
-21m
USD
|
Gross Profit
|
182m
USD
|
Operating Expenses
|
-138.1m
USD
|
Operating Income
|
43.9m
USD
|
Other Expenses
|
-6.8m
USD
|
Net Income
|
37.2m
USD
|
RIGL Profitability Score
Profitability Due Diligence
Rigel Pharmaceuticals Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Score
Rigel Pharmaceuticals Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.
RIGL Solvency Score
Solvency Due Diligence
Rigel Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Score
Rigel Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RIGL Price Targets Summary
Rigel Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
RIGL
is 34.42 USD
with a low forecast of 20.65 USD and a high forecast of 59.85 USD.
Dividends
Current shareholder yield for RIGL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
RIGL
stock under the Base Case scenario is
35.57
USD.
Compared to the current market price of 20.17 USD,
Rigel Pharmaceuticals Inc
is
Undervalued by 43%.